VEGFA and acute kidney injury: Although preclinical studies show that exogenous supplementation of VEGF-A in early AKI can be renoprotective by preserving the microvasculature, its “double-edged sword” effect and the off-target risks of non-specific delivery have shifted research focus (Huang et al., 2023).